Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2002
Business Overview: The Company operates a network of hospitals providing inpatient and outpatient medical and surgical services. Approximately 45% of net operating revenues are derived from Medicare and Medicaid programs. The quarter included the acquisition of two hospitals from local non-profit organizations.
Key Financial Metrics
| Metric (in thousands) | Q1 2002 | Q1 2001 |
|---|---|---|
| Net Operating Revenues | $533,519 | $398,645 |
| Net Income | $27,176 | $10,848 |
| Diluted EPS | $0.27 | $0.12 |
| EBITDA Margin | 17.3% | 19.4% |
| Net Cash from Operating Activities | $48,859 | $31,555 |
| Cash and Cash Equivalents (End of Period) | $23,698 | $23,216 |
| Total Debt (Current + Long-term) | $1,096,957 | N/A |
| Working Capital | $179,208 | N/A |
Note: Total Debt calculated as Current maturities of long-term debt ($88,090) plus Long-term debt ($1,008,867). Working Capital calculated as Total Current Assets ($555,275) minus Total Current Liabilities ($376,067).
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 33.8% to $533.5 million. This was driven by $97.1 million in revenue from seven hospitals acquired in 2001 and 2002, and a 9.5% organic increase at same-hospital locations due to volume and rate increases.
- Profitability: Net income increased 150% to $27.2 million. A significant portion of this increase ($7.0 million impact) is attributable to the adoption of SFAS No. 142, which eliminated goodwill amortization.
- Expense Ratios: Operating expenses as a percentage of revenue increased from 80.6% to 82.7%, primarily due to higher salary and supply costs at recently acquired facilities. However, same-hospital operating expenses decreased to 80.2% due to efficiency gains.
- Interest Expense: Net interest expense decreased 39% to $16.7 million, driven by lower interest rates and a reduced average debt balance following refinancing in late 2001.
- Cash Flow: Operating cash flow increased 55% to $48.9 million. Investing cash outflows increased significantly to $81.7 million, primarily due to $56.1 million spent on facility acquisitions.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects total capital expenditures for the full year 2002 to range between $102 million and $110 million. This includes $70-$75 million for renovations/equipment and approximately $35 million for constructing replacement hospitals required by purchase agreements.
- Liquidity: The Company maintains a credit agreement with $200 million in working capital availability and $252 million for acquisitions. As of March 31, 2002, $166 million was available under the working capital facility and $93 million under the acquisition facility.
- Regulatory Risks: The Company faces risks related to changes in Medicare and Medicaid reimbursement rates, which have historically increased less than inflation. Legislative changes and managed care trends could adversely affect revenue growth.
- Accounting Changes: The adoption of SFAS No. 142 (Goodwill) resulted in a favorable $0.06 per share increase in diluted EPS for the quarter. The Company is currently assessing the impact of SFAS No. 143 regarding asset retirement obligations.
Investor Verification Checklist
- Acquisition Integration: Verify the timeline for realizing cost synergies and margin improvements at the two hospitals acquired in Q1 2002, which currently have lower initial margins.
- Reimbursement Rates: Monitor updates on Medicare and Medicaid payment adjustments and the impact of the Balanced Budget Refinement Act on future revenue projections.
- Debt Covenants: Review the specific financial ratios required by the credit agreement (senior indebtedness, fixed charges) to ensure compliance given the high leverage and ongoing capital expenditure commitments.
- Replacement Hospital Costs: Track the $120 million aggregate estimated cost for constructing four replacement hospitals required through 2005 to assess future cash flow requirements.
- Goodwill Impairment: Although no impairment occurred upon adopting SFAS No. 142, monitor future annual reviews for potential goodwill write-downs given the significant goodwill balance ($1.01 billion).